• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[影响原发性非皮损性皮肤瘙痒的推荐诊断方法]

[Recommended diagnostics for pruritus affecting primary non-lesional skin].

作者信息

Düll M M, Kremer A E

机构信息

Medizinische Klinik 1, Gastroenterologie, Pneumologie, Endokrinologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland.

Klinik für Gastroenterologie und Hepatologie, UniversitätsSpital Zürich, Universität Zürich, Rämistr. 100, 8091, Zürich, Schweiz.

出版信息

Dermatologie (Heidelb). 2024 Aug;75(8):597-605. doi: 10.1007/s00105-024-05380-1. Epub 2024 Jun 28.

DOI:10.1007/s00105-024-05380-1
PMID:38940941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300620/
Abstract

BACKGROUND

Chronic pruritus affecting primary non-lesional skin (CPNL) manifests as a common symptom across a spectrum of diseases spanning various medical specialties. Given the diverse etiological factors involved, diagnosing the underlying condition poses a significant challenge.

OBJECTIVES

To provide a comprehensive overview of clinical, laboratory, and imaging diagnostics for CPNL.

MATERIALS AND METHODS

A thorough literature search on the diagnostics of chronic pruritus was conducted using PubMed with specific keywords "chronic pruritus AND non-lesional skin", "chronic itch AND non-lesional skin", "chronic pruritus AND diagnostics", "chronic itch AND diagnostics", "CKD-aP", "hepatic pruritus", "cholestatic pruritus", and "myeloproliferative neoplasms AND pruritus".

RESULTS

A systematic diagnostic approach is recommended for patients with CPNL, guided by the prevalence of pruritus-associated diseases. Initial basic diagnostics facilitate a cost-effective and focused evaluation during the initial medical assessment. Information pertaining to underlying diseases can be further refined through specialized diagnostic procedures.

CONCLUSIONS

CPNL often presents a diagnostic dilemma. Adopting a stepwise diagnostic strategy facilitates the identification of underlying etiologies, which is crucial for recognizing diseases and administering pruritus-specific pharmacotherapy.

摘要

背景

影响原发性非皮损皮肤的慢性瘙痒(CPNL)是跨多个医学专业的一系列疾病的常见症状。鉴于涉及多种病因,诊断潜在疾病是一项重大挑战。

目的

全面概述CPNL的临床、实验室和影像学诊断。

材料与方法

使用PubMed对慢性瘙痒的诊断进行了全面的文献检索,使用的特定关键词为“慢性瘙痒与非皮损皮肤”、“慢性瘙痒与非皮损皮肤”、“慢性瘙痒与诊断”、“慢性瘙痒与诊断”、“慢性肾脏病相关瘙痒”、“肝性瘙痒”、“胆汁淤积性瘙痒”以及“骨髓增殖性肿瘤与瘙痒”。

结果

对于CPNL患者,建议采用系统的诊断方法,以瘙痒相关疾病的患病率为指导。初始基本诊断有助于在初次医疗评估期间进行经济高效且有针对性的评估。有关潜在疾病的信息可通过专门的诊断程序进一步完善。

结论

CPNL常常带来诊断难题。采用逐步诊断策略有助于识别潜在病因,这对于疾病的识别和实施针对瘙痒的药物治疗至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6329/11300620/cb44cce61005/105_2024_5380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6329/11300620/c55daeeecad2/105_2024_5380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6329/11300620/cb44cce61005/105_2024_5380_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6329/11300620/c55daeeecad2/105_2024_5380_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6329/11300620/cb44cce61005/105_2024_5380_Fig2_HTML.jpg

相似文献

1
[Recommended diagnostics for pruritus affecting primary non-lesional skin].[影响原发性非皮损性皮肤瘙痒的推荐诊断方法]
Dermatologie (Heidelb). 2024 Aug;75(8):597-605. doi: 10.1007/s00105-024-05380-1. Epub 2024 Jun 28.
2
[Systemic pruritus: what is new in diagnosis and treatment?].[全身性瘙痒:诊断与治疗的新进展有哪些?]
Dermatologie (Heidelb). 2022 Aug;73(8):600-608. doi: 10.1007/s00105-022-05027-z. Epub 2022 Jun 30.
3
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.P 物质和神经激肽 1 受体是治疗慢性瘙痒的新靶点。
Br J Dermatol. 2019 Nov;181(5):932-938. doi: 10.1111/bjd.18025. Epub 2019 Jun 6.
4
Diagnostic Work-up of the Itchy Patient.瘙痒患者的诊断检查
Dermatol Clin. 2018 Jul;36(3):179-188. doi: 10.1016/j.det.2018.02.002. Epub 2018 Apr 27.
5
[Clinical shortcuts in the differential diagnosis of pruritus].[瘙痒症鉴别诊断中的临床捷径]
Hautarzt. 2020 Jul;71(7):493-499. doi: 10.1007/s00105-020-04606-2.
6
Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).局限性和全身性皮肤瘙痒症(无潜在瘙痒性皮肤病的慢性瘙痒)的诊断与治疗实用指南
J Dermatol. 2025 Feb;52(2):204-220. doi: 10.1111/1346-8138.17565. Epub 2024 Dec 12.
7
Itch: Epidemiology, clinical presentation, and diagnostic workup.瘙痒:流行病学、临床表现和诊断方法。
J Am Acad Dermatol. 2022 Jan;86(1):1-14. doi: 10.1016/j.jaad.2021.07.076. Epub 2021 Aug 21.
8
[Neuropathy in pruritus medicine : Recommended diagnostics and therapy].[瘙痒医学中的神经病变:推荐的诊断与治疗]
Dermatologie (Heidelb). 2024 Aug;75(8):606-611. doi: 10.1007/s00105-024-05374-z. Epub 2024 Jun 13.
9
Itch in dermatomyositis: the role of increased skin interleukin-31.特应性皮炎患者皮肤组织中白介素-31 的表达及意义
Br J Dermatol. 2018 Sep;179(3):669-678. doi: 10.1111/bjd.16498. Epub 2018 Jun 21.
10
[Chronic itch].[慢性瘙痒]
Ned Tijdschr Geneeskd. 2021 Jan 21;165:D5199.

本文引用的文献

1
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.原发性胆汁性胆管炎中 Seladelpar 的 3 期临床试验。
N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21.
2
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.Elafibranor 治疗原发性胆汁性胆管炎的疗效和安全性。
N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13.
3
Clinical aspects and management of chronic itch.慢性瘙痒的临床特点与管理
J Allergy Clin Immunol. 2023 Jul;152(1):1-10. doi: 10.1016/j.jaci.2023.04.018. Epub 2023 May 11.
4
Evaluation and Management of Pruritus in Primary Biliary Cholangitis.原发性胆汁性胆管炎瘙痒的评估和管理。
Clin Liver Dis. 2022 Nov;26(4):727-745. doi: 10.1016/j.cld.2022.06.009.
5
S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus.S2k指南:慢性瘙痒的诊断与治疗
J Dtsch Dermatol Ges. 2022 Oct;20(10):1386-1402. doi: 10.1111/ddg.14830_g.
6
[Systemic pruritus: what is new in diagnosis and treatment?].[全身性瘙痒:诊断与治疗的新进展有哪些?]
Dermatologie (Heidelb). 2022 Aug;73(8):600-608. doi: 10.1007/s00105-022-05027-z. Epub 2022 Jun 30.
7
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.奥贝胆酸治疗进行性家族性肝内胆汁淤积症:一项随机、安慰剂对照、3 期临床试验。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):830-842. doi: 10.1016/S2468-1253(22)00093-0. Epub 2022 Jul 1.
8
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.马拉硫磷治疗阿拉吉列综合征和胆汁淤积性瘙痒症患者的疗效和安全性(ICONIC):一项随机2期研究。
Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3. Epub 2021 Oct 28.
9
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.一项针对血液透析瘙痒患者的非那雄胺的 3 期临床试验。
N Engl J Med. 2020 Jan 16;382(3):222-232. doi: 10.1056/NEJMoa1912770. Epub 2019 Nov 8.
10
European S2k Guideline on Chronic Pruritus.欧洲 S2k 慢性瘙痒指南。
Acta Derm Venereol. 2019 Apr 1;99(5):469-506. doi: 10.2340/00015555-3164.